Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-07-02 @ 12:44 PM
Study NCT ID:
NCT05308160
Status:
UNKNOWN
Last Update Posted:
2022-04-01
First Post:
2022-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease
Sponsor:
Organization: